A study of Wright-stained smears of rusty sputum from patients with pneumonia has revealed that the number of pneumococci per oil immersion field may be used as a reliable aid in prognosis (1). Furthermore, the specific response of individual patients to serum and to sulfonamides can be readily followed by examination of sputum at intervals during the course of the disease. While the end result of both of these forms of therapy is a reduction in the number of organisms in the sputum and in the lungs (2) The necessity of obtaining good specimens of sputum directly from the patient cannot be overemphasized. Rusty sputum, relatively free of organisms other than pneumococci, gave the most consistent results. Satisfactory specimens were obtained from 90 per cent of the type I through VIII pneumonias. The remaining 10 per cent of the cases failed to produce rusty sputum and were, therefore, excluded from the study. Frankly purulent specimens contained large number of pneumococci which bore little relation to the clinical course or outcome of the pneumonia. Watery mucoid sputum usually showed so many contaminating mouth organisms and desquamated epithelial cells that they had to be discarded.
A study of Wright-stained smears of rusty sputum from patients with pneumonia has revealed that the number of pneumococci per oil immersion field may be used as a reliable aid in prognosis (1) . Furthermore, the specific response of individual patients to serum and to sulfonamides can be readily followed by examination of sputum at intervals during the course of the disease. While the end result of both of these forms of therapy is a reduction in the number of organisms in the sputum and in the lungs (2) , this is accomplished in a different manner by each of the therapeutic agents. Adequate serum, in moderately ill patients, brings about a prompt agglutination of the pneumococci in the sputum within 6 to 12 hours. This is usually folowed by phagocytosis and a gradual reduction in the number of organisms over a period of several days (3, 4) . The sulfonamides, on the other hand, exert a direct bacteriostatic effect which is manifested by a reduction in the number of pneumococci within 12 to 36 hours. A striking decrease is obtained in the sputum, regardless of the number originally present, except in rare instances where drug-fastness develops (3, 5, 6) . In this communication, the sputum counts will be compared as to prognostic significance with the time honored clinical and laboratory criteria, such as type, bacteremia, duration of disease, leukocyte count, age, and degree of involvement.
METHOD
Specimens were obtained from patients on admission to the hospital and at 12-hour intervals throughout the period of production of rusty or bloody sputum. Thin smears were made directly from representative rusty portions and were immediately treated with Wright's blood stain for 3 to 5 minutes. 2 The stain was flooded off without the addition of buffer and the slides were air dried. The capsules of the pneumococci were usually visualized as clear or occasionally as pink zones around the dark blue diplococci. The mucin stained pale pink and the leukocytes and red blood cells were differentiated as on a blood smear.
The necessity of obtaining good specimens of sputum directly from the patient cannot be overemphasized. Rusty sputum, relatively free of organisms other than pneumococci, gave the most consistent results. Satisfactory specimens were obtained from 90 per cent of the type I through VIII pneumonias. The remaining 10 per cent of the cases failed to produce rusty sputum and were, therefore, excluded from the study. Frankly purulent specimens contained large number of pneumococci which bore little relation to the clinical course or outcome of the pneumonia. Watery mucoid sputum usually showed so many contaminating mouth organisms and desquamated epithelial cells that they had to be discarded.
The average number of extracellular encapsulated pneumococci was determined by counting 10 widely separated fields on the slide. A microscopic field was considered suitable for counting if it contained 10 to 15 leukocytes or red blood cells, if organisms other than pneumococci were absent, and if the capsules of the pneumococci were distinctly visible. When good specimens of sputum were obtained, the counts increased or decreased progressively; sudden changes in the number per field were found to be primarily due to poor samples rather than to errors in technique.
By means of the foregoing method, the patients were classified according to the highest sputum count observed at any time during the production of rusty sputum. This count was used whether or not the number of organisms was subsequently reduced as a result of treatment. Although 24 patients showed an increase in sputum count during the period of hospitalization, the classification of these cases on the basis of their highest count did not materially affect the final results. Patients whose sputum counts did not exceed 10 per oil immersion field were classified in group A; those with 11 to 30 organisms were placed in group B; those with counts ranging from 31 to 2Watery specimens were permitted to dry before the addition of stain. in group A and high in group D, regardless of the duration of the disease before the institution of therapy. The fatality rate in groups B and C was intermediate between A and D in both the early and late pneumonias, but tended to be lower when treatment was instituted prior to the fourth day. It should also be noted that the duration of the disease determined to some extent the group to which the patient belonged, since only 14 per cent of cases ill less than 48 hours fell into C and D, wherea's 39 per cent of those with onsets of 144 hours and over were classed in these groups; however, the outcome of the pneumonia was correlated more closely with the sputum counts than with the duration of the disease prior to therapy.
The results in reference to sputum and leukocyte counts are recorded in Table VI . It is generally recognized that the prognosis is poor in pneumonias associated with white cell counts below 5,000 per c. mm. of blood. This was especially true before the introduction of modern chemotherapy. Our fatality rate of 42 per cent in 36 such cases, as compared with 10 per cent in 505 cases with leukocytosis, is representative of the trend in other published reports; however, a breakdown of the cases according to sputum counts showed a much closer correlation of the fatality rate with the number of pneumococci in the sputum than with the leukocyte count. There were no deaths among the 15 cases with leukopenia which showed less than 30 pneumococci per field whereas there were 15 deaths (71 per cent) among the 21 leukopenic cases which showed more than 30 organisms per field. The apparent discrepancy in the fatality rates for the entire series of cases of leukopenia and leukocytosis can be ex- per cent were higher than the average values of 2, These data indicate that the degree of involvement 9, and 30 per cent for groups A, B, anid C, respec-before therapy was a sig-nificant factor in the outt'ively. These discrepancies could be partially ac-come of the pneumonia irrespective of the sputum counted for by the greater incidence of serious count. Extension of the process to additional associated diseases such as cardiac failure, renal lobes during the course of treatment occurred in insufficiency, cirrhosis, and carcinoma in the group only 13 per cent of the cases in groups A and B, over 54 years of age.
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DISCUSSION
The correlation of the sputum counts with other established criteria of prognostic significance was undertaken with the expectation that all factors would contribute substantially to the final fatality rate in pneumonia. It was surprising to find that type, bacteremia, leukopenia, and late pneumonia were of minor importance when the cases were broken down according to the number of pneumococci in the sputum (Tables III, IV , V, and VI). These factors have gradually lost their prognostic significance with the advent of more effective forms of therapy. The increased fatality rates that still prevail in the presence of bacteremia leukopenia, etc., can be explained in part by their frequent association with high sputum counts. Thus, the fatality of 28 per cent among bacteremics was principally due to the fact that 45 per cent of the cases fell into the sputum groups C and D which accounted for 52 of the 62 deaths. On the other hand, the relatively low non-bacteremic fatality rate of 6 per cent was largely due to the fact that only 10 per cent of the patients fell into groups C and D. This small minority accounted for half of the non-bacteremic deaths, but their significance was statistically obscured by the remaining 90 per cent of the cases in groups A and B. Actually, the fatality rate was over three times as high among the 46 patients with negative blood cultures in groups C and D as that among the 123 cases with positive blood cultures in groups A and B. The differences in fatality among the common types of pneumococci could also be explained on the basis of the percentage distribution of cases in the various sputum groups.
The abnormally high fatality rates in patients with types II and III pneumonia have, in the past, been responsible for the emphasis placed on type. The outcome in type III can be attributed, as shown in the following paper, to the capacity of this pneumococcus to form excessive amounts of capsular polysaccharide in the sputum and lungs, whereas the present study has shown that the fatality in type II pneumonia was due (Table III) to the greater proportion of cases with more than 30 pneumococci per field, as compared with other types. The fact that the capsule of the type II pneumococcus is larger than any other except that of type III may be responsible for its ability to multiply in the lung and thus for the higher incidence of cases with sputum counts over 30. From a practical point of view, the outcome in type II, as in types other than III, depends primarily on the number of pneumococci in the sputum of a particular patient during the course of the pneumonia.
The results of the analysis have revealed that age and the degree of involvement were factors which significantly influenced the fatality rates within the four sputum groups. The increase in fatality with age was due chiefly to a corresponding rise in the incidence of groups C and D and partially to the degenerative diseases associated with old age. Some of the critically ill patients over 54 years of age produced a purulent sputum which never became rusty. These patients were unsuitable for study by the present method and it is entirely possible that they may ultimately be placed in a separate and distinct category. We were surprised to find that the extent of consolidation was next in importance to sputum count in determining the outcome of the pneumonia. When fatality rates were calculated by sputum groups, significant differences were noted-between the cases with consolidation limited to one lobe and those with involvement of two or more lobes. These findings suggest that the outcome of pneumonia may be even more closely related to the total number of pneumococci in the two lungs than to their concentration in rusty sputum. There is some evidence to support this view since autopsy studies of fulminating cases have shown that pneumococci are distributed fairly uniformly throughout areas of gray hepatization, red hepatization, and inflammatory edema (2) . Therefore, one might expect to find more pneumococci in the lungs with multiple than with single lobe involvement even though the sputum counts are the same. Another factor which may contribute toward the higher fatality rate is the degree of anoxemia associated with extensive pneumonia.
The utilization of the sputum as a method of prognosis in pneumonia has simplified the statistical approach to this disease. Because of the narrow fatality ranges involved, the generally ac-. cepted practice of alternating cases and analyzing them by type, bacteremia, leukopenia, lobe involvement, duration of disease, therapy, etc., requires unusually large numbers of patients in order to prove the significance of any particular factor. The division into sputum groups, however, permits an unlimited range of fatalities depending only upon the number of cases studied. Such a classification could be duplicated by various investigators and in all probability would not be influenced by seasonal, yearly, or community variations in the virulence of the disease, nor would the usual separation, according to type, bacteremia, leukocyte count, or duration of the disease, be required in order to obtain statistically significant results. Since the primary objective of all studies is to reduce the fatality rate in pneumonia, the division into sputum groups would permit an accurate evaluation of therapeutic agents with greater safety and with relatively few cases. All new drugs submitted for clinical trial would first receive preliminary study in selected patients with initial sputum counts of 20 or less. The efficacy of the drugs could be evaluated in these patients by repeated examination of sputum to determine whether or not they were capable of reducing the number of pneumococci as rapidly as sulfathiazole or sulfadiazine. If the sputum count failed to decrease, or actually increased within a specified time, therapeutic agents of proven value could be readily substituted without subjecting the patients to unnecessary hazards (5, 7) . The most promising drugs could then be studied in cases with more than 30 pneumococci per field in the hope that they might effect a significant reduction of the high fatality rate which still obtains with sulfathiazole and sulfadiazine in this group.
SUMMARY
The average number of pneumococci per oil immersion field in Wright-stained smears of rusty sputum was determined at 12-hour intervals in 678 cases of pneumococcic pneumonia, exclusive of type III. The close relationship between the highest sputum count during the course of the disease, and the outcome, was shown by the fact that the fatality rate was 2 per cent when the pneumococci did not exceed 10 per field, 9 per cent when 11 to 30 were present, 30 per cent when 31 to 75 organisms were found, and 77 per cent when the number exceeded 75. The fatality rate was uniformly low in patients with less than 30 pneumococci per field and uniformly high in those with sputum counts above 30, regardless of the type of pneumococcus, duration of the disease prior to therapy, leukocyte count, and blood culture. The unfavorable prognosis usually attributed to type, bacteremia, leukopenia, and late pneumonia, was due chiefly to the higher incidence of sputum counts over 30 per field in such cases. On the other hand, a comparison of cases whose sputum counts fell within the same range showed that age and extent of consolidation had a definite effect upon the outcome since the fatality rate was significantly higher in patients over 54 or in those with consolidation of 2 or more lobes on admission to the hospital. It was therefore concluded that the number of pneumococci in the sputum had the greatest influence on prognosis and that the most important accessory factors were the extent of involvement and the age of the patient. It was also found that modern chemotherapeutic agents did not appreciably reduce the fatality rate in cases with sputum counts below 30, but were distinctly superior to sulfanilamide and serum in cases with counts above 30. The combination of serum and drugs appeared to be no more effective in the latter group than chemotherapy alone.
